Amgen, Inc. 2025-03-26 Health serious FDA
Health · FDA · Recall #FDA-D-0285-2025
Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For… Recall
Issued March 26, 2025 · Amgen, Inc.
In March 2025, Amgen, Inc. recalled the Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
What you should do
- 1 Stop using Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amgen, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amgen, Inc.
- Category
- Health
- Recall date
- March 26, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy/San Marino, Netherla
- Recall number
- FDA-D-0285-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Amgen, Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.